Literature DB >> 24347571

Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score.

Alessandro Consolaro1, Nicolino Ruperto1, Giulia Bracciolini1, Alessia Frisina1, Maria Chiara Gallo1, Angela Pistorio1, Sara Verazza1, Giorgia Negro1, Valeria Gerloni1, Claudia Goldenstein-Schainberg2, Flavio Sztajnbok3, Nico M Wulffraat4, Alberto Martini5, Angelo Ravelli6.   

Abstract

OBJECTIVE: To determine cutoff values for defining the state of high disease activity (HDA) in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS).
METHODS: For the selection of cutoff values, data from a clinical database including 609 patients were used. Optimal cutoff values were determined against external criteria by calculating the 25th and 10th centile of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria were based on the therapeutic decision made by the attending doctor. Cross-validation was performed using five patient samples that included 1421 patients.
RESULTS: The optimal cutoff values were those obtained through the 90% fixed sensitivity method. The selected JADAS cutoff values were the following: 4.2 and 8.5 for JADAS27 in oligoarthritis and polyarthritis, respectively; 4.2 and 10.5 for both JADAS10 and JADAS71 in oligoarthritis and polyarthritis, respectively. In cross-validation analyses, the cutoff values showed strong ability to discriminate between different levels of American College of Rheumatology paediatric response in two clinical trials and could predict worse functional and radiographic outcome.
CONCLUSIONS: Cutoff values for classifying HDA in JIA using the JADAS were developed. In cross-validation analyses, they proved to have good construct and discriminant validity and ability to predict disease outcome. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Year:  2013        PMID: 24347571     DOI: 10.1136/annrheumdis-2013-204186

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  34 in total

Review 1.  Outcome Scores in Pediatric Rheumatology.

Authors:  Gabriella Giancane; Silvia Rosina; Alessandro Consolaro; Nicolino Ruperto
Journal:  Curr Rheumatol Rep       Date:  2021-03-08       Impact factor: 4.592

2.  Vitamin D levels in juvenile idiopathic arthritis from an equatorial region.

Authors:  Sâmia Araújo de Sousa Studart; Ana Caroline Rocha Melo Leite; Aryana Lushese Lima Feitosa Marinho; Ana Carolina Matias Dinelly Pinto; Carlos Nobre Rabelo Júnior; Rodolfo de Melo Nunes; Hermano Alexandre Lima Rocha; Francisco Airton Castro Rocha
Journal:  Rheumatol Int       Date:  2015-05-20       Impact factor: 2.631

3.  Shared decision-making aid for juvenile idiopathic arthritis: moving from informative patient education to interactive critical thinking.

Authors:  Yasser El Miedany; M El Gaafary; H Lotfy; N El Aroussy; D Mekkawy; S I Nasef; Y Farag; S Almedany; Ghada Wassif
Journal:  Clin Rheumatol       Date:  2019-07-20       Impact factor: 2.980

4.  Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis.

Authors:  Sumantra Sarkar; Md Mahboob Alam; Gargi Das; Supratim Datta
Journal:  Indian J Pediatr       Date:  2017-02-08       Impact factor: 1.967

5.  Long-term breastfeeding influences disease activity in a low-income juvenile idiopathic arthritis cohort.

Authors:  Francisco Airton Castro Rocha; Joaquim Ivo Vasques Dantas Landim; Mariana Lima Nour; Valdenir Freire Peixoto Filho; Leila Nascimento da Rocha; Marco Felipe Castro da Silva; Hermano Alexandre Lima Rocha
Journal:  Clin Rheumatol       Date:  2019-05-06       Impact factor: 2.980

Review 6.  Juvenile idiopathic arthritis.

Authors:  Alberto Martini; Daniel J Lovell; Salvatore Albani; Hermine I Brunner; Kimme L Hyrich; Susan D Thompson; Nicolino Ruperto
Journal:  Nat Rev Dis Primers       Date:  2022-01-27       Impact factor: 65.038

Review 7.  Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases.

Authors:  Erkan Demirkaya; Alessandro Consolaro; Hafize Emine Sonmez; Gabriella Giancane; Dogan Simsek; Angelo Ravelli
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

Review 8.  Innovative Research Design to Meet the Challenges of Clinical Trials for Juvenile Dermatomyositis.

Authors:  Silvia Rosina; Giulia Camilla Varnier; Marta Mazzoni; Stefano Lanni; Clara Malattia; Angelo Ravelli
Journal:  Curr Rheumatol Rep       Date:  2018-04-10       Impact factor: 4.592

9.  Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature.

Authors:  Olha Halyabar; Jay Mehta; Sarah Ringold; Dax G Rumsey; Daniel B Horton
Journal:  Paediatr Drugs       Date:  2019-12       Impact factor: 3.022

Review 10.  Clinical outcome measures in juvenile idiopathic arthritis.

Authors:  Alessandro Consolaro; Gabriella Giancane; Benedetta Schiappapietra; Sergio Davì; Serena Calandra; Stefano Lanni; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-18       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.